Healthcare and life sciences trends 2026

Published on October 12, 2025

The healthcare and life sciences industry enters 2026 facing one of the most transformative periods in its history. Global pricing reforms, shifting evidence standards, rapid innovation cycles, and the rise of AI are reshaping how companies develop, value, launch, and commercialize new medicines. At the same time, emerging markets are becoming strategic growth engines, and new sources of scientific innovation, especially from China, are changing global deal flow.

This year’s trends highlight the forces redefining the rules of engagement for biopharma companies worldwide, and what leaders must do to stay ahead.

Healthcare and life sciences trends 2026

Continue reading on website
Other news

Deposit management trends 2026

October 12, 2025
After two years of steep rate hikes, the global deposit landscape in 2026 looks very different: rates are stabilizing or declining, margins are tightening, and the easy wins from rising interest cycles are gone. The challenge now is growing and defending deposits without simply “paying up?”In this 2026 trends article, we take a closer look at how banks are responding across two of the world’s most

Part 2: What EU-based companies should do to prepare for carbon pricing

October 13, 2025
td {padding: 5px;}tr:hover {background-color: #eee;}In Part 1, we explained why future carbon prices could land anywhere between €70 and €160 per ton and teed up that carbon pricing is quickly becoming a global issue. That level of uncertainty creates real financial risks for firms operating within the EU and beyond, particularly in carbon-intensive sectors.Now, in Part 2, we turn from market dyna